Bruce Randazzo

Company: AnaptysBio

Job title: Vice President Clinical Development

Seminars:

Fireside Chat: Debating the Key Regulatory Hurdles Limiting Dermatological Advancement 3:30 pm

Debating how we present a case for reimbursement on life-limiting versus life-threatening disease Considering what regulators want to see at the very beginning of drug development Establishing clinical endpoints Understanding how reimbursement work in rare disease and the arguments for unmet needRead more

day: Day Two

A Novel Drug Candidate for Alopecia Areata: Rosnilimab, an Agonistic Antibody to the PD-1 Inhibitory Immune Checkpoint Receptor 12:00 pm

Detailing the mode of action for checkpoint inhibitor modulation in chronic inflammatory dermatological disease Cataloguing the dermatological diseases to approach with checkpoint inhibitor modulation Considering endpoints: pharmacodynamics, moving trials beyond 16 weeks (how to know if we have truly reset the immune system), and psycho/social aspects of a life-limiting diseaseRead more

day: Day 2 AM - Track B